key: cord-0700789-ukb1upbr
authors: Goyal, A.; Reeves, D. B.; Schiffer, J. T.
title: Early super-spreader events are a likely determinant of novel SARS-CoV-2 variant predominance
date: 2021-03-24
journal: nan
DOI: 10.1101/2021.03.23.21254185
sha: dcd5e882ff37adfef67153845ee71e2d84e74685
doc_id: 700789
cord_uid: ukb1upbr

The emergence of multiple new SARS-CoV-2 variants, characterized to varying degrees by increased infectivity, higher virulence and evasion of vaccine and infection-induced immunologic memory, has hampered international efforts to contain the virus. While it is generally believed that these variants first develop in single individuals with poor immunologic control of the virus, the factors governing variant predominance in the population remain poorly characterized. Here we present a mathematical framework for variant emergence accounting for the highly variable number of people secondarily infected by individuals with SARS-CoV-2 infection. Our simulations suggest that threatening new variants probably develop within infected people fairly commonly, but that most die out and do not achieve permanence in the population. Variants that predominate are more likely to be associated with higher infectiousness, but also the occurrence of a super-spreader event soon after introduction into the population.

The emergence of multiple new SARS-CoV-2 variants, characterized to varying degrees by increased infectivity, higher virulence and evasion of vaccine and infection-induced immunologic memory, has hampered international efforts to contain the virus. While it is generally believed that these variants first develop in single individuals with poor immunologic control of the virus, the factors governing variant predominance in the population remain poorly characterized. Here we present a mathematical framework for variant emergence accounting for the highly variable number of people secondarily infected by individuals with SARS-CoV-2 infection. Our simulations suggest that threatening new variants probably develop within infected people fairly commonly, but that most die out and do not achieve permanence in the population. Variants that predominate are more likely to be associated with higher infectiousness, but also the occurrence of a super-spreader event soon after introduction into the population.

The emergence and subsequent regional predominance of multiple, highly infectious novel SARS-CoV-2 variants in locations across the globe surprised the scientific and public health communities. Several variants are characterized by more than a dozen new mutations often in the genomic region encoding the viral spike protein (1-3). This rate of mutational change surpassed expectations from previous phylogenetic surveys, which identified population sweeps with single new point mutations only after multiple generations of infection (4) . Immunocompromised hosts are a likely source of these variants. Individuals who have impaired cellmediated or humoral immune function can shed the virus at high viral loads for many weeks, presumably in the relative absence of immune selection pressure (5) (6) (7) (8) . Yet, it remains unknown why certain variants ultimately predominate.

The spread of new variants has had a dramatic impact on global SARS-CoV-2 epidemiology. The B.1.1.7 variant has higher infectivity and virulence than baseline variants (1, 9) , while the B.1.3.5.1 and P.1 variants may have the ability to evade vaccine-and infectioninduced immunologic memory (10) (11) (12) and may also have higher infectivity and virulence (3, 13, 14) . The true abundance of epidemiologically important variants is likely underestimated by sequencing limitations in many global infection hot spots. The B.1.1.7, B.1.3.5.1 and P.1 variants may also undergo further important evolutionary changes over time. Here we perform mathematical modeling to characterize determinants of variant emergence and predominance.

We previously developed a mathematical model which captures the highly variable secondary transmission pattern of SARS-CoV-2 by fitting to empirically observed distributions of serial intervals within transmission pairs, as well as distributions of number of secondary transmissions from infected people (15) (16) (17) . The model explains why the majority of infected people do not infect others while a minority are the index case for large super-spreader events (18) (19) (20) : the exposure contact network of infected people is highly over-dispersed meaning that on rare occasions, an infected person may have dozens of exposure contacts who have the potential to become secondarily infected.

Presumably this phenomenon, which is not observed for influenza (21) , is due to aerosolization of SARS-CoV-2 within crowded indoor environments in which masking is limited (22) . For a super-spreader event to occur, the model projects that the transmitter must also be within the limited time window when they are shedding at a sufficiently high viral load (15) . More model details are in the Methods. We adapted this model to assume that new variants emerge from a single infected person.

We then ran individual stochastic simulation to assess whether variants are present after 100 days or whether they are extinguished. Simulations were governed by an average effective reproductive number (Re) defined as the mean number of secondary infections created per person across the entire population, as well as a value for the "super-spreader parameter" r which captures the variability of a gamma-distributed exposure contact network: the value is low . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted March 24, 2021. ; https://doi.org/10.1101/2021.03.23.21254185 doi: medRxiv preprint (r=0.01) for infections such as influenza in which there is low day-to-day and person-to-person variance in the number of exposure contacts, and high (r=40) for SARS-CoV-2 (15) .

For each parameter set, we ran 1000 simulations. We identified that stochastic burnout of infections is more likely when Re is lower but also when the contact network is highly overdispersed as with SARS-CoV-2 (Figure 1a ). This suggests that most highly infectious SARS-CoV-2 variants will die out when generated within a single person, even when Re is quite high.

We performed an equivalent analysis with 10 starting infections as might occur if an outbreak of a new variant first spreads in a small household or work cluster. The rate of burnout was still relatively high for low Re and high over-dispersion scenarios but decreased substantially with higher Re values for a given variant (Figure 1b) . We next performed an analysis with 100 starting infections as might occur with a larger initial super-spreader event. The rate of burnout was low for all Re values and assumptions regarding contact network dispersion (Figure 1c) .

Therefore, although stochastic extinguishment of novel SARS-CoV-2 variants is likely to be . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted March 24, 2021. ;  common, once roughly 100 cases are established, a variant is likely to continue to expand exponentially in the absence of intensification of non-pharmaceutical interventions (NPIs). Low R e and low number of initial cases is associated with a higher median time to reach 1000 cumulative infections as well as larger variance.

. CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. 4b ). There was a slightly higher likelihood that more infectious variants with higher Re would predominate (Figure 4b) . The timing of variant predominance was highly variable (Figure 4a) . . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted March 24, 2021. ; https://doi.org/10.1101/2021.03.23.21254185 doi: medRxiv preprint

Our simple mathematical model identifies that while higher infectivity is one important predictor of a variant's ultimate predominance in a population, but there is also a substantial element of bad luck. Stochastic burnout is a common event when a pathogen with a reproductive number between 1 and 2 is introduced into a population (23) . The over-dispersed secondary infection rate associated with SARS-CoV-2 further increases the likelihood of stochastic burnout given an equivalent basic reproductive number. This suggests that most new highly infectious variants which emerge from infected individuals never spread substantially in the population. It also raises the more provocative hypothesis that human coronaviruses with pandemic potential such as SARS, MERS and SARS-CoV-2 are introduced into the human population fairly commonly, but that most local outbreaks are avoided due to good fortune alone.

Among variants which do establish a foothold, our model suggests that early large superspreader events, which are relatively rare at the individual level but become increasingly likely as incidence increases during a local outbreak, may determine which variant is likely to predominate. These events provide a head start for a given variant, bypassing the slower exponential growth phase to a phase of epidemic growth which is more deterministic. Superspreader events later during an epidemic growth curve are relatively less important for a variant to achieve predominance.

From a public health perspective, our results provide yet another reason to intensely focus non-pharmaceutical interventions (NPIs) on preventing large super-spreader events. This policy prescription includes prohibition of large indoor gatherings, a focus on adequate ventilation in indoor work environments and schools, and enforcement of highest quality masks (K95 or N95) in circumstances where group exposures cannot be avoided (17) . Prevention of super-spreader . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted March 24, 2021. ; https://doi.org/10.1101/2021.03.23.21254185 doi: medRxiv preprint events will limit number of infections and lower the introduction of new variants and will also decrease the probability that a single large super-spreader event will initiate a more rapid local epidemic as has already occurred in Boston, South Korea and other locations during the pandemic (24, 25) . On the one hand, these individuals may shed for longer and at a higher viral load (5, 7) . Yet, they also may be more ill and therefore quarantined at home or in the hospital limiting contact exposures. Moreover, while all variants will be impacted in the same way by the introduction of NPIs such as masking and physical distancing, the utilization of these interventions varies considerably among regions and over time. Our model does not capture these nuances and in this sense is intended to be phenomenological only.

We demonstrate that new variants are frequently created and introduced into the population during large waves of SARS-CoV-2 infection. Yet, most variants ultimately burn out and those that ultimately predominate likely were associated with early super-spreader events.

These variants are most likely to emerge when the previously dominant variant is decreasing.

. CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted March 24, 2021. ; https://doi.org/10.1101/2021.03.23.21254185 doi: medRxiv preprint

We used the within-host model describing the SARS-CoV-2 infection from our previous study (16) . This model assumes that the contact of SARS-CoV-2 (V) with susceptible cells (S) produces infected cells at rate βVS which then generates new virus at a per-capita rate π. The model also incorporates the death of infected cells mediated by (1) the innate responses (δI ! ) and (2) the acquired immune responses ( mE r E r +ϕ r ) by SARS-CoV-2-specific effector cells (E). The magnitude of the innate immunity is dependent on the infected cell density and the exponent k. The nonlinearity of the acquired responses is captured by the Hill coefficient r that allows for rapid saturation of the killing. Finally, the parameter ϕ defines level of SARS-CoV-2-specific effector cells at which the killing of infected cells becomes half maximal. In the model, the rise of SARS-CoV-2-specific effector cells rise is described in a two-stage manner.

The first stage defines the proliferation of the first precursor cell compartment (M 1 ) at rate ωIM ( and differentiation into a second precursor cell compartment (M 2 ) at a per capita rate q. Finally, second precursor cells differentiate into effector cells at the same per capita rate q and are cleared at rate δ E .

The model is expressed as a system of ordinary differential equations:

. CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. infectiousness and 50% contagiousness and α the Hill coefficient that controls the sharpness in the dose-response curve. We assumed that the viral load-dependent contagiousness (i.e., the probability that virus is passaged to the exposed person's airway) is the same as infectiousness.

We estimate the transmission risk as the product of the infectiousness and contagiousness (15) .

As in our previous model (26), we determined the total exposed contacts of a transmitter within a time step (Δ < ) using a gamma distribution, i.e.

, ρK Δ < , where θ and ρ represent the average daily contact rate and the dispersion parameter, respectively. The true number of exposure contacts (with viral airway exposure) was . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted March 24, 2021. ; https://doi.org/10.1101/2021.03.23.21254185 doi: medRxiv preprint then obtained by multiplying the total exposed contacts and the contagiousness of the transmitter (i.e., ζ < = η @ % P < ). We modelled infectiousness as a Bernoulli event with mean P < , yielding the number of secondary infections within a time step as T @ % = Ber(P < )P < η @ % . Finally, we summed up the number of secondary infections over 30 days since the time of exposure to obtain the individual effective reproduction number, i.e. R C = ∑ T @ % @ % . For each successful transmission, we further assumed that it takes τ days for the first infected cell to produce virus.

In simple steps, we followed the procedure below to estimate Re, 1. Simulate viral load V(t) of a simulated infected individual using the within-host model.

For a given combination of (λ, τ, α, θ, ρ)

Repeat Steps 1 and 2 to estimate R C for 1,000 infected individuals. The population level R C can then be calculating by taking the mean of 1,000 individual R C values. (18, 19, (27) (28) (29) .

. CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted March 24, 2021. ; https://doi.org/10.1101/2021.03.23.21254185 doi: medRxiv preprint Simulating temporal dynamics from the transmission model. For a specific scenario with selected ρ and θ, we followed the procedure below to transform the transmission model into temporal transmission model:

1. Discretize the time-space of 150 days over time steps Δ < of 1 day.

With n < representing the number of transmitters at any time t, we start with presumed n 5 transmitters at t=0 and zero transmitters at the remaining time points.

Starting at t = 0, we first determine the number of transmitters at that time step and then, a. For each of n < transmitters:

i. Simulate V(T) over [t, t + 30] at daily intervals (i.e., ΔT = 1) using the within-host model in eq. 1.

iii. Draw η @D~Γ I A B , ρK ΔT.

iv. Calculate T @D = Ber(P < )P < η @D .

v. Determine times of successful transmission (t E ) as those times 't' where T @D > 0 and the number of secondary transmissions at those time points as

Step 3 for t = Δ < , t = 2Δ < and so on over the discretized time-space of 150 days. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted March 24, 2021. ; https://doi.org/10.1101/2021.03.23.21254185 doi: medRxiv preprint 4.0/day, 5.0/day and 5.5/day, respectively. For a specific scenario with selected ρ, θ and the probability µ of the transmitter transmitting mutant strain, we followed the procedure below to transform the transmission model into multi-class temporal transmission model:

1. Discretize the time-space of 150 days over time steps Δ < of 1 day.

2. With n <7 representing the number of transmitters at any time t of class 'c', we start with presumed n F7 transmitters at t=0 of class c and zero transmitters at the remaining time points for all classes.

3. Starting at t = 0, for each of the seven classes, a. we determine the number of transmitters at that time step of class 'c' and then, b. For each of n <7 transmitters:

i. Simulate V(T) over [t, t + 30] at daily intervals (i.e., ΔT = 1) using the within-host model in eq. 1.

ii. Compute P D [V(T); λ, α].

iii. Draw η @D~Γ I A B , ρK ΔT.

iv. Calculate T @D = Ber(P < )P < η @D .

v. Determine times of successful transmission (t E ) as those times 't' where T @D > 0 and the number of secondary transmissions at those time points as T @D .

vi. Determine which strain was transmitted at times of successful transmission using µ D = Ber(µ). If µ D equals 1, then only a mutant strain is transmitted and the class of the mutant strain is randomly selected from 7 pre-specified classes.

vii. Update n <7 = n <7 + T @D .

. CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted March 24, 2021. ; https://doi.org/10.1101/2021.03.23.21254185 doi: medRxiv preprint 4. Repeat Step 3 for t = Δ < , t = 2Δ < and so on over the discretized time-space of 150 days.

In the case of G = 0.8 (simulated with = 1.1/day), we assume 8 variants instead of 7 and follow steps 1-4 as mentioned above.

. CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted March 24, 2021. ; https://doi.org/10.1101/2021.03.23.21254185 doi: medRxiv preprint

Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England

Emergence and rapid spread of a new severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) lineage with multiple spike mutations in South Africa. medRxiv

Genomics and epidemiology of a novel SARS-CoV-2 lineage in Manaus, Brazil. medRxiv

Cryptic transmission of SARS-CoV-2 in Washington state

Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host

Temporal dynamics of SARS-CoV-2 mutation accumulation within and across infected hosts

Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 Replication in an Immunocompromised Patient

Persistent SARS-CoV-2 infection and increasing viral variants in children and young adults with impaired humoral immunity

Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7

Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity

Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant

Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma. medRxiv

Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence

Model-based estimation of transmissibility and reinfection of SARS-CoV-2 P.1 variant. medRxiv

Viral load and contact heterogeneity predict SARS-CoV-2 transmission and super-spreading events

Potency and timing of antiviral therapy as determinants of duration of SARS-CoV-2 shedding and intensity of inflammatory response

Slight reduction in SARS-CoV-2 exposure viral load due to masking results in a significant reduction in transmission with widespread implementation. medRxiv

Estimating the overdispersion in COVID-19 transmission using outbreak sizes outside China

Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study

High SARS-CoV-2 Attack Rate Following Exposure at a Choir Practice -Skagit County

Transmission of and susceptibility to seasonal influenza in Switzerland from

Aerosol transmission of SARS-CoV-2? Evidence, prevention and control

Stochastic effects on the dynamics of an epidemic due to population subdivision

Phylogenetic analysis of SARS-CoV-2 in Boston highlights the impact of superspreading events

Wrong person, place and time: viral load and contact network structure predict SARS-CoV-2 transmission and super-spreading events. medRxiv

Evaluating Transmission Heterogeneity and Super-Spreading Event of COVID-19 in a Metropolis of China

Serial Interval of COVID-19 among Publicly Reported Confirmed Cases

Clustering and superspreading potential of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections in Hong Kong